indirubin-3'-monoxime has been researched along with Osteogenic Sarcoma in 2 studies
indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fu, B | 1 |
Yin, G | 1 |
Song, K | 1 |
Mu, X | 1 |
Xu, B | 1 |
Zhang, X | 1 |
Zhang, Y | 2 |
Song, L | 1 |
Li, J | 1 |
Lu, X | 1 |
Zhang, B | 1 |
2 other studies available for indirubin-3'-monoxime and Osteogenic Sarcoma
Article | Year |
---|---|
Indirubin-3'-Oxime (IDR3O) Inhibits Proliferation of Osteosarcoma Cells in vitro and Tumor Growth in vivo Through AMPK-Activation and PGC-1α/TFAM Up-Regulation.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Proliferat | 2020 |
Inhibitory effects of indirubin-3'-monoxime against human osteosarcoma.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Focal Adhesion | 2019 |